Present at the 3rd Quality Science of Biologics Summit, 12-13 Aug. 2022, Beijing, China
Present at the 3rd Quality Science of Biologics Summit, 12-13 Aug. 2022, Beijing, China Gaithersb...
As the project partner, BLA Regulatory congratulates ImmuneOnco for receiving Fast Track designation from the FDA to IMM2902 for the treatment of HER-2+ breast cancer patients
As the project partner, BLA Regulatory congratulates ImmuneOnco for receiving Fast Track designation...
As the regulatory consultant, Dr. Frank Li, congratulates BiOneCure Therapeutics on receiving US FDA IND may proceed letter for BIO-106
As the regulatory consultant, Dr. Frank Li, congratulates BiOneCure Therapeutics on receiving US FDA...
BLA Regulatory will present at upcoming Free Senimar on 11 May: Critical Elements of Conducting Early Phase Clinical Trials in the US for APAC Sponsors
BLA Regulatory will present at upcoming Free Senimar on 11 May: Critical Elements of Conducting Earl...
As the project Supporter, BLA congratulates Immorna on receiving IND may proceed letter for JCXH-211 project
As the project Supporter, BLA congratulates Immorna on receiving IND may proceed letter for JCXH-211...
Experience from the Human Drug Approval Online Course
Experience from the Human Drug Approval Online Course BLA Regulatory, LLC, a full-service biopharma ...
As the project partner, BLA Regulatory congratulates Palleon Pharmaceuticals on receiving US FDA approval of E-602 project IND
As the project partner, BLA Regulatory congratulates Palleon Pharmaceuticals on receiving US FDA a...
As a partner of Chiauranib/CS2164 project, BLA Regulatory congratulates Chipscreen on receiving US FDA ODD approval
As a partner of Chiauranib/CS2164 project, BLA Regulatory congratulates Chipscreen on receiving US...
As the project partner, BLA Regulatory congratulates ImmuneOnco on receiving US FDA approval of IMM2902 project IND
As the project partner, BLA Regulatory congratulates ImmuneOnco on receiving US FDA approval of IMM2...
As a partner of Chiauranib/CS2164 project, BLA Regulatory congratulates Chipscreen on receiving US FDA IND approval
As a partner of Chiauranib/CS2164 project, BLA Regulatory congratulates Chipscreen on receiving US F...